SCHEMBL1474478

SCHEMBL1474478

O=C(NCc1cccnc1)c1cc(-c2ccco2)on1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 1.00
ALDH1A1 P00352 6/20 1.00
KMT2A Q03164 5/20 1.00
MEN1 O00255 4/20 1.00
HTT P42858 4/20 1.00
KDM4E B2RXH2 2/20 1.00
PKM P14618 2/20 1.00
RAB9A P51151 9/20 0.76
SMN1; SMN2 Q16637 6/20 0.76
MAPT P10636 1/20 0.68
MAPK1 P28482 1/20 0.68
TP53 P04637 4/20 0.67
LMNA P02545 2/20 0.67
POLB P06746 1/20 0.67
HSD17B10 Q99714 2/20 0.66
ALOX15 P16050 1/20 0.66
ADORA2A P29274 2/20 0.66
ADORA1 P30542 2/20 0.66
ADORA3 P0DMS8 1/20 0.66
ADORA2B P29275 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1178360 0.89 NPC1 (0.80) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL30087181 0.89 NPC1 (0.80) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL1474842 0.87 ALDH1A1 (0.81) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL1475653 0.87 NPC1 (1.00) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL15190413 0.84 NPC1 (0.73) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL1475156 0.84 KMT2A (0.72) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL17661492 0.81 RAB9A (0.81) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL15319936 0.80 ALDH1A1 (0.73) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL928883 0.79 ADORA2A (1.00) NPC1ALDH1A1KMT2AMEN1HTT
SCHEMBL1475078 0.79 NPC1 (0.72) NPC1ALDH1A1KMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971600-B1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK BIOPHARMACEUTICALS CO LTD (KR) 2013-08-21 EP disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
WO-2007078113-A1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK HOLDINGS CO., LTD. (KR) 2007-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 NPC1 2242/4885ALDH1A1 706/4885KMT2A 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.